TradeCraft Clinical Research — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

TradeCraft Clinical Research is a US-based, specialized CRO offering high-touch biostatistics and clinical programming services with a guaranteed regulatory submission acceptance. Founded by statistical programming executives, it differentiates itself through deep therapeutic area expertise, a fully US-based team, and a proprietary data visualization platform called DataVIEWS. The company claims a 100% FDA submission accuracy rate and positions itself as a strategic alternative to large, less specialized CROs for sponsors seeking control and precision in their clinical data.

Clinical Research

Technology Platform

DataVIEWS - A proprietary data visualization platform designed to provide sponsors with clear, real-time views of clinical trial strategy and data, enabling proactive insights and communication.

Opportunities

Growing demand from small-to-mid-sized biotech sponsors for high-touch, expert CRO services to de-risk critical regulatory submissions.

Increasing clinical trial complexity and data volume creates a need for specialized biostatistics and visualization platforms like DataVIEWS.

Risk Factors

Operational and reputational risk from its guaranteed regulatory submission promise; a single failure could be catastrophic.

Revenue is project-based and susceptible to biotech funding cycles.

Scaling its high-expertise, US-based team without diluting quality is a significant challenge.

Competitive Landscape

Competes against large, full-service CROs (like IQVIA, PPD) on service quality and specialization, and against other niche biostatistics CROs. Differentiates through its submission guarantee, deep therapeutic expertise, fully US-based team, and proprietary DataVIEWS platform.

More companies in Digital Health & Biotech SaaS →More companies in United States →